Adial Pharmaceuticals, Inc — Rendiconto Finanziario Trimestrale (NASDAQ:ADIL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 2.37 M
Employee 6
Founded 2010
CEO N/A
Website www.adial.com
Headquarter Delaware, United States
FIGI BBG00HNGDTR4
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

2.37 M Capitalizzazione di mercato

Notizie

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals firma accordo quadro con Molteni per l’Europa

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals in rialzo dopo il cambio di politica della FDA

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals punta a un unico studio pivotale per AD04

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com

Le azioni di Adial Pharmaceuticals crollano dopo l’annuncio di un reverse split 1:25

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split

Adial Pharmaceuticals annuncia un raggruppamento azionario di 1 a 25